Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
1063
-
Total 13F shares, excl. options
-
179M
-
Shares change
-
-19.9M
-
Total reported value, excl. options
-
$13.6B
-
Value change
-
-$1.53B
-
Put/Call ratio
-
0.57
-
Number of buys
-
357
-
Number of sells
-
-537
-
Price
-
$76.01
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q3 2022
1,192 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q3 2022.
NOVARTIS AG - Ordinary Shares (NVS) has 1,063 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 179M shares
of 2.18B outstanding shares and own 8.22% of the company stock.
Largest 10 shareholders include Dodge & Cox (21M shares), PRIMECAP MANAGEMENT CO/CA/ (17.5M shares), LOOMIS SAYLES & CO L P (14.9M shares), BANK OF AMERICA CORP /DE/ (7.22M shares), FRANKLIN RESOURCES INC (7.2M shares), DIMENSIONAL FUND ADVISORS LP (6.5M shares), MORGAN STANLEY (6.11M shares), WELLINGTON MANAGEMENT GROUP LLP (5.09M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (4.53M shares), and CULLEN CAPITAL MANAGEMENT, LLC (3.47M shares).
This table shows the top 1063 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.